Participate in a Clinical Trial

Without the participation of people with MS, it would be impossible to develop new and better therapies and other interventions.

Clinical Trials in MS

The latest clinical research in MS, including trials funded by the Society and trials in progressive MS.

NARCOMS Patient Registry

Register as a willing MS research participant to facilitate multicenter studies. Initiated by the Consortium of MS Centers.

Visit NARCOMS

Posting a Trial

If you would like us to post a study on these pages, please email studies@nmss.org to find out what information you need to submit for review.

Clinical Trials In Your Area

Interested in clinical trials? Simply search by state, type of MS or keyword and see what’s going on in your area.

Clinical Trial: Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

This study will evaluate the effectiveness and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple sclerosis (PPMS), including participants later in their disease course. This study focuses on upper limit disability progres...

Get Details
Research Study: International MS Microbiome Study

This study aims to understand the role of gut bacteria in MS, and by extension allows us to look at the effects of diet and environment on the gut microbiome and MS disease susceptibility and progression. For this study, we are asking that participants donate blood and stool ...

Get Details
Research Study: health behavior and wellness outcomes with wheelchair use

Very little is known about health behaviors and the impact on symptoms in adults with MS who use wheelchairs. The Exercise Neuroscience Research Laboratory at the University of Alabama, Birmingham invites you to participate in a voluntary study of health behaviors in adults wi...

Get Details
Research Study: Pediatric RRMS

Researchers are asking teens with MS and their siblings without MS between the ages of 12-18 to participate in an observational study. With an MRI using a stronger magnet, a specialized picture of the brain, researchers at UTSW might predict an if an individual may have diffi...

Get Details
Research Study: cognitive testing for MS

Researchers are currently enrolling participants in a study of cognitive testing for Multiple Sclerosis. This study compares computerized and in-person cognitive testing, to see how well the results match. Participants will complete assessments of sensory, motor, and cognitive...

Get Details
Clinical Trial: Siponimod in MS

To assess early phase safety and tolerability of converting from approved oral and injectable disease-modifying therapies for relapsing MS to siponimod. The results of this study will guide clinically relevant decisions related to the transition from frequently used therapies ...

Get Details
Research Study: Assessment of Portable Magnetic Resonance Imaging

This study aims to examine the use of a novel portable MRI machine, which has been developed by physicists and physicians at the Massachusetts General Hospital. The MRI machine uses permanent magnets, meaning it doesn’t need liquid helium coolant, makes significantly less sou...

Get Details
Clinical Trial: Malignancies and MS Treatment

VERISMO is a long-term, observational safety study of patients who are newly starting Ocrevus, or Lemtrada, Mavenclad, Tecfidera, Gilenya, Tysabri, or Aubagio. The goal of the study is to determine the full safety profile of Ocrevus compared to these other MS DMTs (disease mod...

Get Details
Clinical Trial: Cognitive Processing Speed Changes in Relapsing MS Treated With Ozanimod (RPC-1063)

A study to determine if oral ozanimod can affect cognitive processing speed in people with relapsing MS. All subjects will receive orally administered ozanimod HCl 1 mg. Please note: In response to the recent developments of the COVID-19 pandemic, sites are implementing me...

Get Details
Clinical Trial: SAR442168

This is a Phase 3, randomized, double-blind, 2-arm, placebo-controlled, parallel-group, multicenter, trial to determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple sclerosis

Get Details

|< < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 > >|

Discover More

Here are a few related topics that may interest you

The National MS Society is Here to Help

Need More Information?

We Are Here

Our MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or contact us online.

Contact an MS Navigator

Newly Diagnosed

If you or somone close to you has recently been diagnosed, access our MS information and resources.

Start Here

Participate in a Clinical Trial

Clinical Trials in MS

NARCOMS Patient Registry

Posting a Trial

Share

Clinical Trials In Your Area

Clinical Trial: Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

Research Study: International MS Microbiome Study

Research Study: health behavior and wellness outcomes with wheelchair use

Research Study: Pediatric RRMS

Research Study: cognitive testing for MS

Clinical Trial: Siponimod in MS

Research Study: Assessment of Portable Magnetic Resonance Imaging

Clinical Trial: Malignancies and MS Treatment

Clinical Trial: Cognitive Processing Speed Changes in Relapsing MS Treated With Ozanimod (RPC-1063)

Clinical Trial: SAR442168

Share

Discover More

The National MS Society is Here to Help

We Are Here